Responsive Image

 

 

Responsive Image

Enfermedades digestivas

Líneas de investigación

Enfermedad inflamatoria intestinal (colitis ulcerosa y enfermedad de Crohn) y enfermedades relacionadas
Desarrollo de nuevas técnicas endoscópicas diagnósticas y terapéuticas para el diagnóstico de lesiones neoplásicas y preneoplásicas del tracto digestivo

Foto grupo

Actividades del grupo:

Papel de la aféresis leucocitaria.

Características e historia natural de la enfermedad inflamatoria intestinal preclínica.

Enfermedad perianal. Eficacia de los tratamientos biológicos y papel de la resonancia magnética en su evaluación.

Eficacia de los fármacos biológicos en el tratamiento de las complicaciones de la enfermedad inflamatoria intestinal.

Coordinador/a del grupo

  •   Jose Luis Cabriada Nuño
      Coordinador del grupo
      CV resumen


Miembros del grupo

  Marta Aduna de Paz
 
 
  Juan Antonio Arévalo Serna
 
 
  Inmaculada Barredo Santamaría
 
 
  Ainara Elorza Echániz
 
 
  Alberto Fernández Atutxa
 
 
  Alain Huerta Madrigal
 
 
  Irene Moraleja Yudego
 
 
  Iago Rodríguez Lago
 
 
  Ainhoa Rodríguez Pescador
 
 
  Cristina San Juan López
 
 
  Daniel Oyón Lara
 
 

Publicaciones del grupo

Sanz B,Rezola C,Arrieta H,Fernandez A,Lora I,Gil J et al. High serum angiotensin-converting enzyme 2 activity as a biomarker of frailty in nursing home residents. Exp. Gerontol. 2022. 158. 111655. IF:4,032. (2).

Barreiro M,Riestra S,Calafat M,Soto MP,Calvo M,Sanchez E et al. Management and long-term outcomes of Crohn's disease complicated with enterocutaneous fistula: ECUFIT study from GETECCU. J. Crohns Colitis. 2022. IF:9,071. (1).

Gutierrez G,Ruiz F,Ariz U,Fernandez A,Mulas MJ,Benito E et al. Successful breastfeeding among women with intention to breastfeed: From physiology to socio-cultural factors. Early Hum. Dev. 2022. 164. 105518. IF:2,082. (3).

Rodriguez I,Hollenbach M,Archibugi L,Ciocan D,Libanio D,Nuzzo A et al. Young GI angle: Challenges and opportunities as a trainee editor: The United European Gastroenterology journal experience. United European Gastroenterol. J. 2022. 10(3):p. 348-353. IF:4,623. (2).

Gutierrez A,Zapater P,Ricart E,Gonzalez M,Gordillo J,Olivares D et al. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Front Med (Lausanne). 2022. 9. p. 823900-823900. IF:5,091. (1).

Zabana Y,Marin I,Rodriguez I,Vera I,Martin MD,Guerra I et al. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. J Clin Med. 2022. 11. (2):421. IF:4,241. (1).

Algaba A, Guerra I, Ricart E, Iglesias E, Mañosa M, Gisbert JP et al. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry. Dig Dis Sci. 2021; 66(6): 2014-2023. DOI:10.1007/s10620-020-06424-x.

Rodriguez Lago I, Alonso Galan H, Cabriada JL. Cytokine storm in IBD: balancing the risks of IBD medical therapy. Gastroenterology. 2021; 160(5): 1878-1880. DOI:10.1053/j.gastro.2020.12.073.

Bermejo F, Jimenez L, Algaba A, Vela M, Bastida G, Merino O et al. Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. Inflamm Bowel Dis. 2021; 28(1): 41-47. DOI:10.1093/ibd/izab015.

Gutierrez A, Rodriguez Lago I. How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data. Front Med (Lausanne). 2021; 8: 640813-640813. DOI:10.3389/fmed.2021.640813.

Calvo XC, Carpio D, Rodriguez Lago I, Garcia Vicuna R, Acosta MB, Roura XJ et al. Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterol Hepatol. 2021; 44(8): 587-598. DOI:10.1016/j.gastrohep.2021.01.007.

Torres J, Halfvarson J, Rodriguez Lago I, Hedin CRH, Jess T, Dubinsky M et al. Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease. J Crohns Colitis. 2021; 15(9): 1443-1454. DOI:10.1093/ecco-jcc/jjab048.

Barreiro de Acosta M, Marin Jimenez I, Rodriguez Lago I, Guarner F, Espin E, Bradley IF et al. Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment (vol 43, pg 649, 2020). Gastroenterol Hepatol. 2021; 44(4): 320-320. DOI:10.1016/j.gastrohep.2021.02.001.

Rodriguez Lago I, Barreiro de Acosta M. Risk of Depression During the Natural History of Inflammatory Bowel Disease: The Phantom Menace. Inflamm Bowel Dis. 2021; 27(9): 99-100. DOI:10.1093/ibd/izab067.

Rodriguez Lago I, Agirre U, Intxaurza N, Cantero D, Cabriada JL, Barreiro de Acosta M. Increased use of healthcare resources during the preclinical period of inflammatory bowel disease. Dig Liver Dis. 2021; 53(7): 927-930. DOI:10.1016/j.dld.2021.04.002.

Sebastian delaCruz M, Olazagoitia Garmendia A, Madrigal AH, Garcia Etxebarria K, Mendoza LM, Fernandez Jimenez N et al. A Novel Noninvasive Method Based on Salivary Inflammatory Biomarkers for the Screening of Celiac Disease. Cell Mol Gastroenterol Hepatol. 2021; 12(4): 1511-NA. DOI:10.1016/j.jcmgh.2021.05.016.

Magro F, Nuzzo A, Abreu C, Libanio D, Rodriguez Lago I, Pawlak K et al. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J. 2021; 9(7): 750-765. DOI:10.1002/ueg2.12115.

Chaparro M, Garre A, Nunez Ortiz A, Diz Lois Palomares MT, Rodriguez C, Riestra S et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J Clin Med. 2021; 10(13). DOI:10.3390/jcm10132885.

Rodriguez Lago I, Barreiro de Acosta M. The natural history of extraintestinal manifestations after surgery in inflammatory bowel disease: Never give up!. United European Gastroenterol J. 2021; 9(7): 748-749. DOI:10.1002/ueg2.12127.

Sainz E, Zabana Y, Miguel I, Fernandez Clotet A, Beltran B, Nunez L et al. Clinical features, therapeutic requirements and evolution of patients with Crohn's disease and upper gastrointestinal involvement (CROHNEX study). Aliment Pharmacol Ther. 2021; 54(8): 1041-1051. DOI:10.1111/apt.16547.

Ferreiro Iglesias R, Hernandez Camba A, Serrano Labajos R, Rodriguez Lago I, Zabana Y, Barreiro de Acosta M et al. SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project. Gastroenterol Hepatol. 2021. DOI:10.1016/j.gastrohep.2021.08.004.

Rodriguez Lago I, Mesonero F, Hijos Mallada G, Canas M, Saldana R, Savini C et al. Self-medication with analgesics reported by patients with ulcerative colitis: An anonymous survey. Gastroenterol Hepatol. 2021; 45(6): 457-463. DOI:10.1016/j.gastrohep.2021.07.009.

Guijarro LG, Cano Martínez D, Toledo Lobo MV, Salinas PS, Chaparro M, Gómez Lahoz AM et al. Relationship between IGF-1 and body weight in inflammatory bowel diseases: Cellular and molecular mechanisms involved. Biomed Pharmacother. 2021; 144: 112239-112239. DOI:10.1016/j.biopha.2021.112239.

Bermejo F, Jimenez L, Algaba A, Vela M, Bastida G, Merino O et al. Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy. Inflamm Bowel Dis. 2021; 28(1): 150-150. DOI:10.1093/ibd/izab242.

Pico S, Parras A, Santos Galindo M, Pose Utrilla J, Castro M, Fraga E et al. CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's disease. Sci Transl Med. 2021; 13(613). DOI:10.1126/scitranslmed.abe7104.

Stephens C, Robles Diaz M, Medina Caliz I, Garcia Cortes M, Ortega Alonso A, Sanabria Cabrera J et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021; 75(1): 86-97. DOI:10.1016/j.jhep.2021.01.029.

Hernandez Camba A, Arranz L, Vera I, Carpio D, Calafat M, Lucendo AJ et al. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry. Dig Liver Dis. 2021; 54(5): 635-641. DOI:10.1016/j.dld.2021.10.002.

Rodriguez Lago I, Perez CG, Calafat M, Soto MP, Calvo M, Rodriguez ES et al. Long-term outcomes of enterocutaneous fistula complicating Crohn's Disease: The ECUFIT study from GETECCU. J Crohns Colitis. 2021; 15: 70-71. DOI:10.1093/ecco-jcc/jjab073.071.

Rodriguez Lago I, Agirre U, Intxaurza N, Cantero D, Barreiro de Acosta M, Cabriada JL. Healthcare resources utilisation prior to the diagnosis of ulcerative colitis and Crohn's disease. J Crohns Colitis. 2021; 15: 270-270. DOI:10.1093/ecco-jcc/jjab076.336.

Eek A, Protopapas AA, Pisani A, Barberio B, Frias Gomes C, Noviello D et al. VARIATION IN IBD CARE AND EDUCATION ACROSS EUROPE RESULTS FROM A PAN-EUROPEAN SURVEY. Gut. 2021; 70: 30-30. DOI:10.1136/gutjnl-2021-BSG.53.

Iglesias RF, Camba AH, Saldana R, Rodriguez Lago I, Zabana Y, Barreiro de Acosta M et al. Adherence to vaccination recommendations in patients with Inflammatory Bowel Disease: a long way for improving. J Crohns Colitis. 2021; 15: 410-411. DOI:10.1093/ecco-jcc/jjab076.527.

Abdo YZ, Marin Jimenez I, Rodriguez Lago I, Vera I, Martin MD, Guerra I et al. Comorbidities and epidemiological risk factor but not immunosuppressive therapies increase the risk of COVID-19 in Inflammatory Bowel Disease (IBD): An ENEIDA-based, case-control study. J Crohns Colitis. 2021; 15: 78-79. DOI:10.1093/ecco-jcc/jjab073.079.

Deza DC, Calvo LJL, Mainar J, Ricart E, Gisbert JP, Tirado MR et al. Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry. J Crohns Colitis. 2021; 15: 298-299. DOI:10.1093/ecco-jcc/jjab076.388.

Abdo YZ, Marin Jimenez I, Rodriguez Lago I, Estesos ER, Meijilde S, Ramos L et al. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. J Crohns Colitis. 2021; 15: 553-554. DOI:10.1093/ecco-jcc/jjab076.729.

Gisnsero FM, Zabana Y, Fernandez Cloret A, Sola A, Caballol B, Leo E et al. Inflammatory complications of the pouch, and therapetic requirements after colectomy in patients with ulcerative colitis. Results from the RESERVO Study of GETECCU. J Crohns Colitis. 2021; 15: 198-199. DOI:10.1093/ecco-jcc/jjab076.232.

Kral J, Nakov R, Lanska V, Barberio B, Benech N, Blesl A et al. Large differences in IBD care and education across Europe, first results of the pan-European VIPER survey. J Crohns Colitis. 2021; 15: 75-76. DOI:10.1093/ecco-jcc/jjab073.076.

Rodriguez Lago I, Fernandez Clotet A, Mesonero F, Garcia Alonso FJ, Casanova MJ, Fernandez de la Varga M et al. Long-term outcomes of biologic therapy in Crohn's disease complicated with internal fistulizing disease: BIOSCOPE study from GETECCU. J Crohns Colitis. 2021; 15: 377-378. DOI:10.1093/ecco-jcc/jjab076.481.

Chaparro M, Donday MG, Suarez CC, Rubio S, Figueira M, Martinez IP et al. Safety of Inflammatory Bowel Disease drugs during pregnancy and breastfeeding: Mothers and babies' outcomes (DUMBO registry). J Crohns Colitis. 2021; 15: 86-88. DOI:10.1093/ecco-jcc/jjab073.091.

Chaparro M, Garre A, Ortiz AN, Palomares MTDL, Rodriguez C, Riestra S et al. Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study. J Crohns Colitis. 2021; 15: 18-20. DOI:10.1093/ecco-jcc/jjab075.019.

Ciria MM, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S et al. Management and outcome of postoperative Crohn's Disease in the elderly as compared to young adults: Data from Eneida registry. J Crohns Colitis. 2021; 15: 69-70. DOI:10.1093/ecco-jcc/jjab073.070.

Arechederra M, Rullan M, Amat I, Oyon D, Zabalza L, Elizalde M et al. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures. Gut. 2021. DOI:10.1136/gutjnl-2021-325178.

Oyon Lara D, Fernandez Atucha A, Lopez M, Cabriada Nuno JL. Polycystic pancreas, gastrointestinal manifestation of von Hippel-Lindau disease. Gastroenterol Hepatol. 2021; 45: 73-74. DOI:10.1016/j.gastrohep.2021.11.011.

Sanz B, Arrieta H, Rezola Pardo C, Fernandez Atutxa A, Garin Balerdi J, Arizaga N et al. Low serum klotho concentration is associated with worse cognition, psychological components of frailty, dependence, and falls in nursing home residents. Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-88455-6.

Caldas M,Perez A,Castro M,Bujanda L,Lucendo AJ,Rodrigo L,Huguet JM,Perez J,Molina J,Barrio J,Fernandez L,Lanas A,Perona M,Dominguez M,Ortuño J,Gomez BJ,Almela P,Botargues JM,Núñez Ó,Modolell I,Gomez J,Ruiz R,De la Coba C,Huerta A,Iyo E,Pozzati L,Anton R,Barenys M,Angueira T,Fernández M,Campillo A,Alcedo J,Pajares R,Mego M,Bermejo F,Dominguez JL,Tito L,Fernandez N,Pabon M,Cosme A,Mata P,Alcaide N,Ariño I,Di T,Garre A,Puig I,Nyssen OP,Megraud F,O'Morain C,Gisbert JP,EuReg HP. European Registry on  Helicobacter pylori  Management: Effectiveness of First and Second-Line Treatment in Spain. Antibiotics-Basel. 2020. 10. (1):13. IF:4,639. (2).

Carretero C,Prieto C,Angos R,Betes M,Herraiz M,de la Riva S,Zozaya F,Fernandez M,Rodriguez I,Munoz M. Pan-enteric capsule for bleeding high-risk patients. Can we limit endoscopies?. Rev. Esp. Enferm. Dig. 2020. IF:2,086. (4).

Mesonero F,Julia B,Saldana R,Savini C,Canas M,Cea L,Feo L,Fernandez S,Rodriguez I,ACCU GAG. Self-medication with oral corticosteroids reported by patients with ulcerative colitis: characteristics, reasons and patients' behaviors. Eur. J. Gastroenterol. Hepatol. 2020. 33. (4):p. 501-507. IF:2,566. (4).

Rodriguez I,Marigorta UM,Acosta MB. Preclinical inflammatory bowel disease: back to the future. Gastroenterology. 2020. 160. (1):p. 475-476. IF:22,682. (1).

Canete F,Manosa M,Perez I,Barreiro M,Gonzalez RC,Nos P,Iglesias E,Gutierrez A,Bujanda L,Gordillo J,Rios R,Casanova MJ,Villoria A,Rodriguez I,Lopez P,Garcia A,Ramirez P,Navarro M,Taxonera C,Barrio J,Ramos L,Navarro P,Benitez O,Calafat M,Domenech E. Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis. Clin Transl Gastroenterol. 2020. 11. (8):p. 218-218. IF:4,488. (2).

Martin N,Rodriguez I,Barredo I,Cabriada JL. Apoptotic colitis owing to dolutegravir. Gastroenterol. Hepatol. 2020. 43. (10):p. 638-639. IF:2,102. (4).

Rodriguez I,Ramirez C,Merino O,Azagra I,Maiz A,Zapata E,Higuera R,Montalvo I,Fernandez M,Arreba P,Carrascosa J,Iriarte A,Munoz M,Cabriada JL,Barreiro M. Early microscopic findings in preclinical inflammatory bowel disease. Dig. Liver Dis. 2020. 52. (12):p. 1467-1472. IF:4,088. (2).

Barreiro M,Marin I,Rodriguez I,Guarner F,Espin E,Ferrer I,Gutierrez A,Beltran B,Chaparro M,Gisbert JP,Nos P,en representacion G. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment. Gastroenterol. Hepatol. 2020. 43. (10):p. 649-658. IF:2,102. (4).

Rodríguez I,Gisbert JP. The role of immunomodulators and biologics in the medical management of stricturing Crohn's disease. J. Crohn's Colitis. 2020. 14. (4):p. 557-566. IF:9,071. (1).

Marin I,Zabana Y,Rodriguez I,Marin L,Acosta MB,Esteve M,en representacion Y. [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)]. Gastroenterol. Hepatol. 2020. 43. (7):p. 408-413. IF:2,102. (4).

Chaparro M,Guerra I,Iborra M,Cabriada JL,Bujanda L,Taxonera C,Garcia V,Marin I,Barreiro M,Vera I,Martin MD,Hernandez B,Mesonero F,Sempere L,Gomollon F,Hinojosa J,Bermejo F,Beltran B,Rodriguez A,Banales JM,Olivares D,Aguilar P,Menchen L,Ferreiro R,Blazquez I,Benitez B,Guijarro LG,Marin A,Bernardo D,Gisbert JP,PREDICROHN Study Group from G. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease. Eur. J. Gastroenterol. Hepatol. 2020. 32. (5):p. 588-596. IF:2,566. (4).

Rodriguez I,Castro J,Fernandez A,Mesonero F,Lopez A,Lopez A,Marquez L,Clos A,Canete F,Vicuna M,Nantes O,Merino O,Matallana V,Gordillo J,Elorza A,Vicente R,Casanova MJ,Ferreiro R,Perez P,Benitez JM,Taxonera C,Garcia MJ,Martin E,Aguirre U,Gisbert JP,Young GRP. Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease. Aliment. Pharmacol. Ther. 2020. 51. (9):p. 870-879. IF:8,171. (1).

Ramos L,Hernandez A,Rodriguez I,Carrillo M,Cejas L,Elorza A,Alonso I,Vela M,Hidalgo A,Hernandez Alvarez N,Rodriguez GE,Rodriguez Y,Tardillo C,Diaz L,Eiroa D,Aduna M,Garrido MS,Larena JA,Cabriada JL,Quintero E. Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease. Gastroenterol. Hepatol. 2020. 43. (8):p. 439-445. IF:2,102. (4).

Rodriguez I,Ramirez de la Piscina P,Elorza A,Merino O,Ortiz de Zarate J,Cabriada JL. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain). Gastroenterology. 2020. 159. (2):p. 781-783. IF:22,682. (1).

Albéniz E,Gimeno AZ,Fraile M,Ibáñez B,Guarner C,Alonso P,Álvarez MA,Gargallo CJ,Pellisé M,Zabala FR,Herreros de Tejada A,Nogales Ó,Martínez D,Múgica F,Peña J,Espinós J,Huerta A,Álvarez A,Gonzalez JM,Navajas F,Martínez JG,Redondo E,Mas JM,Sábado F,Rivero L,Saperas E,Soto S,Rodríguez J,López L,Rodríguez M,Iriarte MR,González AE,Pardeiro R,Cortázar EV,Concepción M,Álvarez PH,Hernández JC,Cobian J,Santiago J,Jiménez A,López B,García O,Martínez F,Pérez F,Carbó J,Enguita M. Clinical validation of risk-scoring systems to predict risk of delayed bleeding after endoscopic mucosal resection of large colorectal lesions. Gastrointest. Endosc. 2020. 91. (4):p. 868-8783. IF:9,427. (1).

Skuja V,Nakov R,van Y,Rodriguez I,Acedo P,Mikolasevic I,Nitsche U,Heinrich H,Dignass A,Young GRP. How to start a Young GI Section in your country: A cookbook. United European Gastroenterol. J. 2020. 8. (3):p. 355-358. IF:4,623. (2).

Macaluso FS,Rodriguez I. JAK inhibition as a therapeutic strategy for inflammatory bowel disease. Curr. Drug Metab. 2020. 21. (4):p. 247-255. IF:3,731. (2).

Rivero L,Arnau C,Herrero J,Remedios D,Alvarez V,Albéniz E,Calvo P,Gordillo J,Puig I,López J,Huerta A,López M,Salces I,Peñas B,Parejo S,Rodriguez de Santiago E,Herraiz M,Carretero C,Gimeno AZ,Saperas E,Alvarez C,Moreira R,Rodriguez de Miguel C,Ocaña T,Moreira L,Carballal S,Sánchez A,Jung G,Castells A,Llach J,Balaguer F,Pellisé M. White-light Endoscopy is Adequate for Lynch Syndrome Surveillance in a Randomized and Non-inferiority Study. Gastroenterology. 2020. 158. (4):p. 895-9041. IF:22,682. (1).

Fiallegas M,Moraleja I,Sampedro B,de Castro L,Jiménez I,Martín N,Cabriada JL. Giant sigmoid diverticulum. Gastroenterol. Hepatol. 2020. 43. (1):p. 30-31. IF:2,102. (4).

Elorza A,Rodríguez I,Martínez P,Hidalgo A,Aguirre U,Cabriada JL. Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease. Gastroenterol. Hepatol. 2020. 43. (10):p. 614-619. IF:2,102. (4).

Rodriguez I,Hoyo JD,Perez A,Garrido A,Casanova MJ,Chaparro M,Fernandez A,Castro J,Garcia MJ,Sanchez S,Ferreiro R,Baston I,Piqueras M,Careda LEIBD,Mena R,Suarez C,Cordon JP,Lopez A,Marquez L,Arroyo M,Alfambra E,Sierra M,Cano N,Delgado P,Morales V,Aparicio JC,Guerra I,Aullo C,Merino O,Arranz L,Hidalgo MA,Llao J,Plaza R,Molina G,Torres P,Perez P,Romero MG,Herrera C,Armesto E,Mesonero F,Frago S,Benitez JM,Calvo M,Martin MCL,Elorza A,Larena A,Pena E,Rodriguez MC,Miguel JD,Botella B,Olmos JA,Lopez L,Aguirre U,Gisbert JP,Young G. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease. United European Gastroenterol. J. 2020. 8. (9):p. 1056-1066. IF:4,623. (2).

Rivero L,Gavric A,Herrero J,Remedios D,Alvarez V,Albeniz E,Gordillo J,Puig I,Lopez J,Huerta A,Lopez M,Salces I,Penas B,Parejo S,Rodriguez E,Herraiz M,Carretero C,Gimeno AZ,Saperas E,Alvarez C,Arnau C,Ortiz O,Sanchez A,Jung G,Balaguer F,Pellise M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. Endoscopy. 2020. IF:10,093. (1).

Rodriguez I,Barreiro M. Look at Both Sides of the Coin in Determining Risk of Complicated Crohn's Disease. Clin. Gastroenterol. Hepatol. 2020. 19(7):p. 1503-1504. IF:11,382. (1).

Heinrich H,Rodr?guez I,Nakov R,Skuja V,Acedo P,Nitsche U,Mikolasevic I,van Y,Friends Y. Young GI Societies in Europe: 2019 update. United European Gastroenterol. J. 2020. 8(2):p. 227-232. IF:4,623. (2).

Rodriguez I,Zabana Y,Barreiro M. Diagnosis and natural history of preclinical and early inflammatory bowel disease. Ann. Gastroenterol. 2020. 33(5):p. 443-452.

Sanchez Sanchez, Cesar, Hernani, Maria Tolin, Alvarez Calatayud, Guillermo, Miranda Cid, Carmen, Manuel Navas, Victor, Marin-Jimenez, Ignacio, Menchen, Luis, Garcia Fernandez, Paloma, Merino Sanchez-Canete, Ana, Arevalo, A., Aznal, E., Azual, P., Barros, P., Bautista, A., Blanco, M., Blasco-Alonso, J., Bodas, A., Botija, G., Busquets, E., Campoy, C., Carabano, I, Carro, M. A., Chicano, F. J., Crujeira, V, Donado, P., Eizaguirre, F. J., Escartin, L., Caamano B, Fernandez, Cebrian S, Fernandez, Fernandez, Fernandez, Gonzalez P, Ferrer, Galera, R., Galicia, G., Peris M, Garcia, Romero R, Garcia, de Caldas R, Gonzalez, Grande, L., Iglesias, C., Irastorza, I., Jimenez, S., Juste, M., La Orden, E., Lopez, M. J., Lorenzo, H., Loverdos, I, Magallares, L., Manzano, M. J., de Carpi J, Martin, Marugan, J. M., Masiques, M. L., Medina, E., Menendez, C., Montraveta, M., Moreno, A., Codoceo R A, Munoz, Ochoa, C., Ortigosa, L., Pena, L., Perez-Moneo, B., Pociello, N., Rivero, M. C., Rodriguez, A., Martinez C, Rodriguez, Romero, J., Rosell, A., Valverde F, Sanchez, Segarra, O., Solar, A., Soria, M., Torrecilla, J., Torres, R., Gomez C, Tutau, Vazquez, R., Vecino, R., Alvarez A M, Vegas, Aguilar, P., Andreu, M., Arajol, C., Baston, I, Benitez, J. M., Botellla, B., Calvo, M., Camacho, L., Carrillo, M., Ceballos, D., Crespo, B., Duque, J. M., Fernandez, L., Ferreiro, R., Ferrer, I, Fraile, M., Gallach, M., Gallego, M. R., Delgado E, Gomez, Guerra, I, Casbas A, Gutierrez, Villalba L, Hernandez, Huguet, J. M., Iborra, M., Leo, E., Lucendo, A. J., Perez T, Martinez, Mesonero, F., Miguel, J. O., Penate, M., Galindo P, Perez, Gisbert J, Perez, Piqueras, M., Plaza, R., Ramirez, J. J., Ramos, L., Gloria E, Rodriguez Gonzalez, Gutierrez C, Rodriguez, Rodriguez-Lago, I, Rubio, S., Sainz, E., Torres A, Sanchez, Sapina, A., Saro, C., Sese, E., Trapero, A. M., Vargas, M., Vega, P., Spanish Soc Pediat Gastroenterolog, Spanish Working Grp Crohns Dis Ulc. Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives. Rev Esp Enferm Dig. 2019; 111(11): 833 - 838. FI: 1,858(Q4). DOI: 10.17235/reed.2019.6310/2019.

Rodriguez-Lago, Iago, Ferreiro-Iglesias, Rocio, Nos, Pilar, Gisbert, Javier P., GETECCU. Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey. Gastroenterol. Hepatol.. 2019; 42(2): 90 - 101. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2018.09.002.

Acedo, Pilar, Heinrich, Henriette, van Herwaarden, Yasmijn, Nakov, Radislav, Nitsche, Ulrich, Rodriguez-Lago, Iago, Salaga, Maciej, Skuja, Vita. UEG Young Talent Group: What do we do?. United Eur. Gastroenterol. J.. 2019; 7(1): 166 - 168. FI: 3,453(Q2). DOI: 10.1177/2397847319826451.

Calafat, M, Manosa, M, Panes, J, Nos, P, Iglesias, E, Vera, I, Lopez-Sanroman, A, Guardiola, J, Taxonera, C, Minguez, M, Martin, MD, de Castro, L, Riestra, S, Rivero, M, Garcia-Planella, E, Calvet, X, Garcia-Lopez, S, Andreu, M, Gomollon, F, Barrio, J, Esteve, M, Rodriguez, A, Gisbert, JP, Gutierrez, A, Hinojosa, J, Arguelles, F, Busquets, D, Bujanda, L, Lazaro, J, Sicilia, B, Merino, O, Martinez, P, Bermejo, F, Lorente, R, Barreiro-de-Acosta, M, Rodriguez, C, Fe, M, Piqueras, M, Romero, P, Rodriguez, E, Roncero, O, Llao, J, Alcain, G, Riera, J, Sierra, M, Salazar, LIF, Jair, V, Navarro, M, Montoro, MA, Munoz, C, Lucendo, AJ, Van Domselaar, M, Moraleja, I, Huguet, M, Ramos, L, Ramirez, P, Almeda, P, Pajares, R, Khorrami, S, Madrigal, RE, Sese, E, Trapero, AM, Legido, J, Abad, A, Canete, F, Cabre, E, Domenech, E. Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry. J. Crohns Colitis. 2019; 13(1): 328 - 329. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.561.

Rodriguez-Lago, I., Castro-Poceiro, J., Fernandez-Clotet, A., Mesonero, F., Lopez-Sanroman, A., Lopez-Garcia, A., Marquez, L., Clos-Parals, A., Canete, F., Vicuna, M., Nantes, O., Merino, O., Matallana Royo, V., Gordillo, J., Elorza, A., Sanz, P., Casanova, M. J., Ferreiro-Iglesias, R., Perez-Galindo, P., Benitez, J. M., Taxonera, C., Garcia Garcia, M. J., Martin Arranz, E., Calafat, M., Martin-Cardona, A., Munoz Nunez, F., Miquel-Cusachs, J. O., Sainz Arnau, E., Gisbert, J. P., Young IBD Grp GETECCU. Efficacy and safety of tacrolimus in Crohn's disease: a nationwide, multi-centric study from GETECCU. J. Crohns Colitis. 2019; 13(1): 207 - 208. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.347.

Rodriguez-Lago, I., Castro-Poceiro, J., Fernandez-Clotet, A., Mesonero, F., Lopez-Sanroman, A., Lopez-Garcia, A., Marquez, L., Clos-Parals, A., Canete, F., Vicuna, M., Nantes, O., Merino, O., Matallana Royo, V., Gordillo, J., Elorza, A., Vicente, R., Casanova, M. J., Ferreiro-Iglesias, R., Perez-Galindo, P., Benitez, J. M., Taxonera, C., Garcia Garcia, M. J., Arranz, E. Martin, Calafat, M., Martin-Cardona, A., Munoz Nunez, F., Miquel-Cusachs, J. O., Sainz Arnau, E., Gisbert, J. P., Young IBD Grp GETECCU. Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU. J. Crohns Colitis. 2019; 13(1): 52 - 53. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy222.078.

Chaparro, Maria, Barreiro-de Acosta, Manuel, Echarri, Ana, Almendros, Rosendo, Barrio, Jesus, Llao, Jordina, Gomollon, Fernando, Vera, Maribel, Luis Cabriada, Jose, Guardiola, Jordi, Guerra, Ivan, Beltran, Belen, Roncero, Oscar, Busquets, David, Taxonera, Carlos, Calvet, Xavier, Ferreiro-Iglesias, Rocio, Ollero Pena, Virginia, Bernardo, David, Donday, Maria G., Garre, Ana, Godino, Ana, Diaz, Ana, Gisbert, Javier P.. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients. Dig Dis Sci. 2019; 64(3): 846 - 854. FI: 2,937(Q3). DOI: 10.1007/s10620-018-5362-3.

Balsa A., Lojo-Oliveira L., Alperi-López M., García-Manrique M., Ordóñez-Cañizares C., Pérez L., Ruiz-Esquide V., Corrales A., Narváez J., Rey-Rey J., Rodríguez-Lozano C., Ojeda S., Muñoz-Fernández S., Nolla J.M., García-Torrón J., Gamero F., García-Vicuña R., Hernández-Cruz B., Campos J., Rosas J., García-Llorente J.F., Gómez-Centeno A., Cáliz R., Sanmartí R., Bermúdez A., Abasolo-Alcázar L., Fernández-Nebro A., Rodríguez-Rodríguez L., Marras C., González-Gay M.Á., Hmamouchi I., Martín-Mola E.. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study. Reumatol. Clin.. 2019; 15(2): 102 - 108. FI: (Q). DOI: 10.1016/j.reuma.2017.06.002.

Rodriguez-Lago, Iago, Sempere, Laura, Gutierrez, Ana, Nunez, Andrea, Leo Carnerero, Eduardo, Hinojosa, Esther, Mora, Maria, Canete, Fiorella, Manosa, Miriam, Herrera, Claudia, Beltran, Belen, Fores, Ana, Arjona, Dolores, Barreiro-de Acosta, Manuel, Khorrami, Sam, Aguirre, Urko, Ginard, Daniel, Luis Cabriada, Jose. Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis. Scand. J. Gastroenterol.. 2019; 54(4): 459 - 464. FI: 2,152(Q4). DOI: 10.1080/00365521.2019.1600715.

Canete, Fiorella, Manosa, Miriam, Lobaton, Triana, Mesonero, Francisco, Rodriguez-Lago, Iago, Cabre, Eduard, Cabriada, Jose L., Lopez-Sanroman, Antonio, Domenech, Eugeni. Nivolumab-induced immune-mediated colitis: an ulcerative colitis look-alikereport of new cases and review of the literature. Int. J. Colorectal Dis.. 2019; 34(5): 861 - 865. FI: 2,641(Q2). DOI: 10.1007/s00384-019-03268-4.

Chaparro, Maria, Barreiro-de Acosta, Manuel, Manuel Benitez, Jose, Cabriada, Jose Luis, Jose Casanova, Maria, Ceballos, Daniel, Esteve, Maria, Fernandez, Hipolito, Ginard, Daniel, Gomollon, Fernando, Lorente, Rufo, Nos, Pilar, Riestra, Sabino, Rivero, Montserrat, Robledo, Pilar, Rodriguez, Cristina, Sicilia, Beatriz, Torrella, Emilio, Garre, Ana, Garcia-Esquinas, Esther, Rodriguez-Artalejo, Fernando, Gisbert, Javier P., EpidemIBD Study Grp GETECCU. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Ther. Adv. Gastroenterol.. 2019; 12: UNSP 1756284819847034. FI: 3,961(Q2). DOI: 10.1177/1756284819847034.

Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP, Spanish GETECCU group (ENEIDA Project). Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.. J. Crohns Colitis. 2019; 13(12): 1492 - 1500. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjz094.

Andújar X, Loras C, González B, Socarras M, Sanchiz V, Boscà M, Domenech E, Calafat M, Rodríguez E, Sicilia B, Calvet X, Barrio J, Guardiola J, Iglesias E, Casanova MJ, Ber Y, Monfort D, López-Sanromán A, Rodríguez-Lago I, Bujanda L, Márquez L, Martín-Arranz MD, Zabana Y, Fernández-Bañares F, Esteve M, ENEIDA registry of GETECCU. Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry.. Surg. Endosc.. 2019; 34(3): 1112 - 1122. FI: 3,209(Q1). DOI: 10.1007/s00464-019-06858-z.

de Miguel, Eugenio, Joven-Ibanez, Beatriz, Galindez, Eva, Urrego-Laurin, Claudia, Luz Garcia-Vivar, Maria, Fernandez-Carballido, Cristina, Garcia Llorente, Jose Francisco, Castro Villegas, Maria del Carmen, Tornero, Carolina, Juanola-Roura, Xavier, Esperanza Working Grp. THE VALUE OF SACROILIAC JOINT RADIOGRAPHS IN THE EARLY SPONDYLOARTHRITIS ESPERANZA COHORT. Ann. Rheum. Dis.. 2019; 78(2): 472 - 472. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.7696.

Tornero, Carolina, Urrego-Laurin, Claudia, Luz Garcia-Vivar, Maria, Fernandez-Carballido, Cristina, Juanola-Roura, Xavier, Garcia Llorente, Jose Francisco, Castro Villegas, Maria del Carmen, Joven-Ibanez, Beatriz, Galindez, Eva, de Miguel, Eugenio, Esperanza Working Grp. RELIABILITY OF SACROILIAC JOINT RADIOGRAPHS IN THE EARLY SPONDYLOARTHRITIS ESPERANZA COHORT. Ann. Rheum. Dis.. 2019; 78(2): 1821 - 1821. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.7768.

Irati, Urionaguena, Chinchilla Gallo, P. Sandra, Hernandez Gomez, Sandra, Garcia Llorente, Jose Francisco, Aizpurua Manso, Izaskun, Vegas Revenga, Nuria. DENSITOMETRY VALUES CHANGE WHEN STOPPING DENOSUMAB. Ann. Rheum. Dis.. 2019; 78(2): 1896 - 1896. FI: 14,299(Q1). DOI: 10.1136/annrheumdis-2019-eular.4338.

Domenech, Eugeni, Panes, Julian, Hinojosa, Joaquin, Annese, Vito, Magro, Fernando, Sturniolo, Giacomo Carlo, Bossa, Fabrizio, Fernandez, Francisco, Gonzalez-Conde, Benito, Garcia-Sanchez, Valle, Dignass, Axel, Herrera, Jose Manuel, Cabriada, Jose Luis, Guardiola, Jordi, Vecchi, Maurizio, Portela, Francisco, Ginard, Daniel. Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial (vol 12, pg 687, 2018). J. Crohns Colitis. 2019; 13(6): 814 - 814. FI: 7,827(Q1). DOI: 10.1093/ecco-jcc/jjy211.

Rodríguez-Lago I, Barreiro-de Acosta M. Short Disease Duration Does Not Always Indicate Early Crohn's Disease.. Clin. Gastroenterol. Hepatol.. 2019; 17(8): 1646 - 1646. FI: 7,958(Q1). DOI: 10.1016/j.cgh.2019.01.017.

Carmona-Abellan, Mar, Rodriguez-Lago, Iago, Luis Cabriada, Jose, Carlos Gomez-Esteban, Juan. The relationship between inflammatory bowel disease and Parkinson's disease: true or fiction?. Scand. J. Gastroenterol.. 2019; 54(7): 886 - 889. FI: 2,152(Q4). DOI: 10.1080/00365521.2019.1641739.

Barreiro-De Acosta, Manuel, Domenech, Eugeni, Martin Arranz, Maria Dolores, Garcia Sanchez, Valle, Gutierrez Casbas, Ana, Chaparro, Maria, Alcain, Guillermo, Iborra, Marisa, Taxonera, Carlos, Rodriguez-Lago, Iago, Menchen, Luis, Khorrami, Sam, Romero, Cristina, Cea-Calvo, Luis, Julia, Berta. Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study. Expert Rev. Gastroenterol. Hepatol.. 2019; 13(8): 807 - 813. FI: 2,991(Q3). DOI: 10.1080/17474124.2019.1626717.

Rodríguez-Lago I, Merino O, López de Goicoechea MJ, Aranzamendi M, Zubiaurre L, Muro N, Ortiz de Zárate J, Cilla G, Cabriada JL. Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.. Gastroenterol. Hepatol.. 2019; 42(9): 542 - 547. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2019.03.016.

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.. Inflammatory Bowel Dis.. 2019; 26(4): 606 - 616. FI: 4,005(Q2). DOI: 10.1093/ibd/izz192.

Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez-Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gómez I, Benitez García B, Guijarro LG, Marin AC, Bernardo D, Marsal S, Julia A, Gisbert JP. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease. Ther. Adv. Gastroenterol.. 2019; 12: 1756284819867848. FI: 3,961(Q2). DOI: 10.1177/1756284819867848.

Barreiro-de Acosta, Manuel, Gutierrez, Ana, Rodriguez-Lago, Iago, Espin, Eloy, Ferrer Bradley, Isabel, Marin-Jimenez, Ignacio, Beltran, Belen, Chaparro, Maria, Gisbert, Javier P., Nos, Pilar, GETECCU. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis. Gastroenterol. Hepatol.. 2019; 42(9): 568 - 578. FI: 1,126(Q4). DOI: 10.1016/j.gastrohep.2019.08.001.

Rodriguez-Lago, Iago, Benitez, Jose M., Sempere, Laura, Saez-Gonzalez, Esteban, Barreiro-de Acosta, Manuel, de Zarate, Jone O., Cabriada, Jose L.. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?. J. Clin. Apheresis. 2019; 34(6): 680 - 685. FI: 3,088(Q2). DOI: 10.1002/jca.21746.

Tesis del grupo

Autor/a: Iago Rodríguez Lago. Título: "Enfermedad inflamatoria intestinal preclínica: características de la enfermedad, pronóstico y necesidades de tratamiento". Directores/as: Dr. Miguel Muñoz Navas, Dr. Manuel Barreiro de Acosta.

© 2022 IIS Biocruces Bizkaia